CLINICAL_TRIALS
trial_result
· 2014-01-29
Clinical Trial Update: Darbepoetin Alfa and Anemia of Cancer [Phase 2]
Summary
Phase 2 study of Darbepoetin alfa for anemia of cancer; the trial was terminated and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Anemia, Anemia of Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-29